The single nucleotide polymorphism rs4986790 (c.896A>G) in the gene
COVID-19
IL-6
SARS-CoV-2
TLR4
disease severity
polymorphism
prognostic marker
rs4986790
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2024
2024
Historique:
received:
13
12
2023
accepted:
29
01
2024
medline:
4
3
2024
pubmed:
4
3
2024
entrez:
4
3
2024
Statut:
epublish
Résumé
Several factors, such as hypertension and diabetes mellitus, are known to influence the course of coronavirus disease 2019 (COVID-19). However, there is currently little information on genetic markers that influence the severity of COVID-19. In this study, we specifically investigated the single nucleotide polymorphism (SNP) rs4986790 in the We analyzed the influence of demographics, pre-existing conditions, inflammatory parameters at the time of hospitalization, and We confirmed that younger patient age and absence of pre-existing conditions were protective factors against disease progression. Furthermore, when comparing patients with mild SARS-CoV-2 infection with patients who required hospitalization or intensive care or even died due to COVID-19, the AG/GG genotype of In this study, we identified an additional genetic factor that may serve as an invariant predictor of COVID-19 outcome. The
Sections du résumé
Background and aims
UNASSIGNED
Several factors, such as hypertension and diabetes mellitus, are known to influence the course of coronavirus disease 2019 (COVID-19). However, there is currently little information on genetic markers that influence the severity of COVID-19. In this study, we specifically investigated the single nucleotide polymorphism (SNP) rs4986790 in the
Methods
UNASSIGNED
We analyzed the influence of demographics, pre-existing conditions, inflammatory parameters at the time of hospitalization, and
Results
UNASSIGNED
We confirmed that younger patient age and absence of pre-existing conditions were protective factors against disease progression. Furthermore, when comparing patients with mild SARS-CoV-2 infection with patients who required hospitalization or intensive care or even died due to COVID-19, the AG/GG genotype of
Conclusion
UNASSIGNED
In this study, we identified an additional genetic factor that may serve as an invariant predictor of COVID-19 outcome. The
Identifiants
pubmed: 38433829
doi: 10.3389/fimmu.2024.1355193
pmc: PMC10904585
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1355193Informations de copyright
Copyright © 2024 Zacher, Schönfelder, Rohn, Siffert and Möhlendick.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.